A therapeutic trial of valganciclovir in patients with uveitis and positive Epstein-Barr virus early antigen D IgG titers.
Boonsopon, Sutasinee, Armin Maghsoudlou, Ninani Kombo, and Stephen Foster. 2015. “A Therapeutic Trial of Valganciclovir in Patients With Uveitis and Positive Epstein-Barr Virus Early Antigen D IgG Titers.”. Eur J Ophthalmol 26 (1): 30-5.